Top 40 Biotechnology Angel Investors in Canada (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Bootstrapped Debt Financing
Angel
|
3 | United States, Canada, United Kingdom | Pre-Seed, Seed | Software, Information Technology, Apps | $11k–$1.1M |
|
Tom Williams
Angel
|
2 | United States, Canada, India | Seed, Series A, Series B | Software, Health Care, Financial Services | $1.3M–$67M |
|
Ray Muzyka
Angel
|
2 | Canada, United States | Seed, Pre-Seed | Health Care, Software, Information Technology | $320k–$2.5M |
|
T. Chen Fong
Angel
|
2 | Canada, Singapore, United States | Seed, Angel, Pre-Seed | Software, Artificial Intelligence, Biotechnology | $227k–$9.3M |
|
Ajay Agrawal
Angel
|
2 | Canada, United States | Seed, Pre-Seed, Series C | Health Care, Artificial Intelligence, Medical | $1.1M–$4.3M |
|
Noel Hall
Angel
|
2 | Canada, United States | Seed, Angel | Biotechnology, Genetics, Life Science | $2.5M–$5.5M |
|
Naval Ravikant
Angel
|
2 | United States, India, United Kingdom | Seed, Series A | Software, FinTech, Blockchain | $1M–$25M |
|
Balaji Srinivasan
Angel
|
2 | United States, India, Singapore | Seed, Series A, Pre-Seed | Blockchain, Cryptocurrency, Software | $800k–$28M |
|
Joe Betts-Lacroix
Angel
|
1 | United States | Seed | Life Science, Biotechnology, Pharmaceutical | $3.6M–$4.3M |
|
Ran Tuttnauer
Angel
|
1 | Israel, Canada, United States | Seed, Series A | Health Care, Big Data, Internet | |
|
Jacky Chen
Angel
|
1 | Canada, United States, China | Seed, Pre-Seed | Software, Health Care, Information Technology | $362k–$3.1M |
|
Frederic Ors
Angel
|
1 | Canada | Seed | Medical, Health Care, Biotechnology | |
|
Ethan Oren Perlstein
Angel
|
1 | United States, Canada | Seed | Biotechnology, Cannabis, Biopharma | $2M–$4.5M |
|
Jed McCaleb
Angel
|
1 | United States, Canada | Seed, Series A, Initial Coin Offering | Internet, Payments, Space Travel | $1M–$300M |
|
Lee Lau
Angel
|
1 | Canada | Seed, Convertible Note | Software, Wearables, Internet of Things | $788k–$1.4M |
|
Lip-Bu Tan
Angel
|
1 | United States, Israel, India | Seed, Series A, Series B | Software, Artificial Intelligence, Semiconductor | $3M–$70M |
|
Nilesh Bansal
Angel
|
1 | Canada | Seed | SaaS, Big Data, Hardware | $1.4M–$1.5M |
|
Paul Buchheit
Angel
|
1 | United States, Canada, India | Seed, Series A, Angel | Software, E-Commerce, Health Care | $100k–$13M |
|
Lance Tracey
Angel
|
1 | Canada, United States | Seed, Angel, Pre-Seed | Internet, Software, Communities | $1M–$4M |
|
Amarjit Gill
Angel
|
1 | United States, Canada | Seed, Series A, Convertible Note | Software, Information Technology, Artificial Intelligence | $1.1M–$30M |
|
Daniel Debow
Angel
|
1 | Canada, United States | Seed, Series A, Pre-Seed | Software, SaaS, FinTech | $788k–$32M |
|
Jon Oringer
Angel
|
1 | United States, United Kingdom, France | Seed, Pre-Seed, Series A | Software, Information Technology, E-Commerce | $100k–$31M |
|
Rami Essaid
Angel
|
1 | United States, India, Canada | Seed, Pre-Seed | SaaS, Software, News | $1k–$20M |
|
Dan Schultz
Angel
|
1 | Canada, United States | Seed | SaaS, Data Mining, Life Science | $1M–$3M |
|
Collin Terpstra
Angel
|
1 | Canada | Series A | Medical, Health Care, Biotechnology | |
|
Ryan Pawell
Angel
|
1 | Canada, United States | Seed | Medical, Biopharma, Biotechnology | |
|
Dennis Bennie
Angel
|
1 | Canada, United States | Seed, Pre-Seed, Series A | Software, Hardware, Health Care | $20k–$15M |
|
Milad Alucozai
Angel
|
1 | United States, Canada, United Kingdom | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Medical | $110k–$55M |
|
Haig Farris
Angel
|
1 | Canada, United States | Seed, Pre-Seed | Biotechnology, Genetics, Life Science | |
|
Lawrence Bloch
Angel
|
1 | Canada | Series B, Debt Financing | Neuroscience, Therapeutics, Biotechnology | |
|
Shaz Khan
Angel
|
1 | Canada | Debt Financing | Hardware, Biometrics, Health Care | |
|
Sandra MacPherson
Angel
|
1 | Canada | Seed | Genetics, Biotechnology, Medical Device | |
|
bumpkins profile
Angel
|
1 | United States, Canada, India | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Robotics | $325k–$57M |
|
Martin LeBlanc
Angel
|
1 | Canada | Seed | Medical, Health Care, Biotechnology | |
|
Claudette McGowan
Angel
|
1 | Canada | Angel, Grant | Apps, Hospital, Software | |
|
Carol Leaman
Angel
|
1 | Canada | Seed, Angel, Series A | Health Care, Hospital, Neuroscience | |
|
Wei Guo
Angel
|
1 | United States, China, Canada | Seed, Series A, Angel | Software, Artificial Intelligence, Health Care | $200k–$19M |
|
Greg Wolfond
Angel
|
1 | United States, Canada | Seed, Series A | Internet, Software, Delivery | $1.1M–$7M |
|
Jeff Mallett
Angel
|
1 | Canada, United States | Angel, Series A | E-Commerce, Media and Entertainment, iOS | |
|
Robert Simon
Angel
|
1 | Canada, United States | Series A, Seed | Software, Health Care, SaaS | $1.2M–$62M |
| Access all 40 angel investors in Canada Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Bootstrapped Debt Financing
Show more...Investment focus
- Industry: Software, Information Technology, Apps
- Stage:Pre-Seed, Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 33
- Round size: Seed $120k–$1.1M; Pre-Seed $11k–$1.1M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Kornem Energy — Kornem Energy provides energy intelligence and mobile-fuel delivery and diesel delivery on demand for the needs of today, tomorrow, and our future.We are eliminating the traditional fuel supply chain infrastructure using IOT & a compact terminal-to-car logistics aggregation, through service, automation and mobility.This enables us todeliver fuel directly to the customers who can request fuel delivery wherever they are, through our mobile app, while bridging the gap between feedstock aggregation, quality-assurance and end-user accessibility.No more expensive real estate, no more extensive supply chain. Just #FuelToYou
- SymbaSync — SymbaSync™ helps organizations maximize return on employee investment by providing Human Resources Software to source, qualify, and engage employees to populate project teams. SymbaSync’s tools increase employee satisfaction improving employee ownership, engagement, and retention. SymbaSync provides a company with a complete overview of up-to-dateemployee skills, interests, and workplace preferences.
- Tactii — We do rapid prototyping on machine learning and analytics for small companies. Our main focus is to bring down the budget for small companies and startups who want to explore things in Machine Learning. Affordable Machine Learning for startups and small companies. We are partnering up with various startups and small companies.
Tom Williams
Show more...Investment focus
- Industry: Software, Health Care, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, India
Investor stats
- Total investments: 77
- Round size: Seed $1.3M–$5M; Series A $7M–$21M; Series B $10M–$67M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Unito — Unito is taking on a major problem that people are passionate about solving: they make it easier to collaborate across teams. They don't make users learn new tools and change the way they work. By connecting work management tools, they allow managers, cross-functional teams, departments, and entire companies to benefit from seamlesscollaboration and improved communication. The app syncs projects across a number of tools like Trello, Asana, JIRA, GitHub, Wrike, Zendesk & Hubspot. This is a hard problem of semantics, synchronization, and APIs.
- North One — NorthOne is an online Business Account with built-in features to make business banking fast and easy. No overdraft fees. No minimum balance. No hidden fees.
- Possible Finance — Get money in minutes, build credit history and avoid hidden fees with Possible Finance. Apply in the app with just a few taps and manage money on your terms.
Originally trained as a medical doctor, Dr. Ray Muzyka cofounded BioWare, a video game development studio focusing on story and character, in the early 1990s. He practiced emergency/family medicine for two years full time, with medicine transitioning to part-time over the following decade as he focused on his role as BioWare’s CEO. BioWare wasacquired by Electronic Arts in 2007, and Dr. Muzyka took on the roles of Senior Vice President at Electronic Arts and General Manager of EA’s BioWare division, which grew over the next five years to span eight development locations worldwide with about 2000 staff (1400 full time). He retired from video games in October 2012, with his third “career chapter” at ThresholdImpact, where he focused on sustainable, profitable impact investing: mentoring and angel investing in information technology, new media, and medical innovations with social entrepreneurs. An active angel investor and entrepreneurial mentor, Dr. Muzyka is a member of the Young Presidents’ Organization, the A100, the Ashoka Support Network, and the Board of Governors of the University of Alberta (serving as Chair of the Human Resources Committee and on the Learning and Discovery Committee and as a member of the University of Alberta Advancement Council). He is Chair of the University of Alberta’s entrepreneur Venture Mentoring Service, a venture advisor at iNovia Venture Capital, and a member of the Alberta Research and Innovation Advisory Committee and the Alberta Premier’s Advisory Committee on the Economy. He also serves on a number of private company boards. He previously served on the board of the Academy of Interactive Arts and Sciences from 2001-2008 and was on the Board of Trustees of the Stollery Children’s Health Foundation from 2012-2015. He was inducted into the Academy of Interactive Arts and Sciences’ Hall of Fame in 2011 and received the International Game Developers’ Choice Awards 2013 Lifetime Achievement Award. Dr. Muzyka received the inaugural Alumni Innovation Award in 2015 from the University of Alberta. He additionally was named as the 2017 Allard Chair in Business at the MacEwan University’s School of Business and as an Honorary Paul Harris Fellow by Rotary Club International in 2016, in recognition for his philanthropic efforts. Other awards include entry into Canada’s Top 40 under 40 and Ernst and Young’s 2001 Entrepreneur of the Year (IT, Prairies).He obtained his Bachelor of Medical Science from the University of Alberta in 1990, his Doctorate of Medicine from there in 1992, and his MBA from the University of Western Ontario (Ivey School of Business) in 2001.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 25
- Round size: Seed $320k–$2.5M; Pre-Seed $320k–$1.9M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Leadoptik — Leadoptik is a California-based company is currently operating in stealth mode.
- Modality.AI, Inc. — Modality.ai is an AI-powered platform that detects health conditions using conversational AI. Through dialogue and video, Modality.AI interacts conversationally with the patient to provide health assessment anywhere, anytime. Its system analyzes multimodal data which allows continuous screening and assessing of patients’ health.
- Gray Oncology Solutions — Gray Oncology Solution is a healthcare enterprise software company that commercializes GrayOS, the operating system for oncology.
Dr. Fong is a Professor Emeritus at the Faculty of Medicine, University of Calgary. He was formerly the Head of the Department of Radiology at the University of Calgary and the Calgary Health Region. Dr. Fong is active in funding and nurturing start-up companies. Over the past two decades, he funded over 50 companies in diverse technology sectors,with an emphasis in medical devices. Dr. Fong is the co-founder and board member of Calgary Scientific Inc. and is also on the board of Clarius Mobile Health, Cohesic Inc. and Innovere Medical. In addition to seed investing, Dr. Fong is active in the Calgary community sitting on six charitable boards and foundations.In 2015, Dr. Fong joined the Creative Destruction Lab (CDL) at the University of Toronto business school as a mentor. CDL helps young entrepreneurs to shape or pivot their nascent ideas. He is widely credited with launching CDL at the Haskayne School of Business at the University of Calgary, bringing together seasoned business leaders from Alberta, Canada and the US to grow budding companies. Dr. Fong is on the Strategic Advisory Board of CDL and a Fellow of CDL in Toronto, Montreal, Calgary and Vancouver. In 2017, Dr. Fong was named to the Order of Canada for his contribution to medical technology innovation and philanthropy.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Seed, Angel, Pre-Seed
- Geography: Canada, Singapore, United States
Investor stats
- Total investments: 12
- Round size: Seed $227k–$9.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oncoustics AI — Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.
- SunGreenH2 — SunGreenH2 creates the world's highest performance advanced materials for electrolysis i.e. green hydrogen production. Achieve high efficiency, low cost green H2 production on site for your application in the Power-to-X, Hydrogen refuelling, Energy Storage and Buildings sectors. Revolutionising zero emissions and improving profitability.
- EZee Assist — EZee Assist provides instant answers to franchisee operational questions. Continue using preferred channels of support and start receiving instant answers.
Ajay Agrawal is the Co-Founder of Sanctuary Cognitive Systems Corporation. He previously worked at Queen's School of Business as a Assistant Professor. Ajay Agrawal attended the University of British Columbia.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical
- Stage:Seed, Pre-Seed, Series C
- Geography: Canada, United States
Investor stats
- Total investments: 6
- Round size: Seed $1.4M–$4.3M; Pre-Seed $1.1M–$1.4M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- ALT TEX — ALT TEX is creating sustainable textiles regenerated from post-industrial waste.
- EcoPackers — Explore Chicken Road Casino in Canada! Play Chicken Road game and enjoy thrilling casino experiences with top bonuses and features.
- EZee Assist — EZee Assist provides instant answers to franchisee operational questions. Continue using preferred channels of support and start receiving instant answers.
Noel Hall is the Director of Corporate of Wellcome Trust. He is a former Board Director, Co-founder, and President of Aspreva Pharmaceuticals Corp. He attended the University of London.
Show more...Investment focus
- Industry: Biotechnology, Genetics, Life Science
- Stage:Seed, Angel
- Geography: Canada, United States
Investor stats
- Total investments: 3
- Round size: Seed $2.5M–$5.5M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
- Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, India, Singapore
Investor stats
- Total investments: 234
- Round size: Seed $2.3M–$15M; Pre-Seed $800k–$4.2M; Series A $6M–$28M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- BizScout — BizScout is an online platform of Off market deals for verified buyers and sellers.
- Parallax — Parallax offers a cross-border payments platform for freelancers, remote workers, and businesses. The service enables receiving international client payments, holding funds in USD, exchanging currencies, and sending money to domestic bank accounts and mobile wallets. Users manage balances and transfers through a web app with quoted rates anditemized fees. The platform supports global payouts and recurring disbursements to partners and team members. Compliance measures include identity verification and transaction monitoring aligned with regulatory standards. Documentation and support resources guide account setup, funding, and cash-out.
- Blueprint Bryan Johnson — On the surface, Blueprint may seem something about health, wellness and aging. It's really a system to make tomorrow better for you, me, the planet and our shared future with AI.
Joe Betts-Lacroix is the Founder and CEO of Retro. He previously worked at Recursion as an Advisor. Joe Betts-Lacroix attended Harvard University.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $3.6M–$4.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VitaDAO — Join VitaDAO, a community owned collective funding early stage longevity research. We fund and commercialize longevity therapeutics.
- Spring Discovery — Giving Scientists AI Superpowers
Ran Tuttnauer
Show more...Investment focus
- Industry: Health Care, Big Data, Internet
- Stage:Seed, Series A
- Geography: Israel, Canada, United States
Investor stats
- Total investments: 6
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Innovopro — InnovoPro is committed to bringing unique plant-based protein ingredients to the global food market in order to create nutritious, tasty, safe, and sustainable food products. With an excellent nutritional profile, free from properties and wide usability in the food industry, InnovoPro’s chickpea protein is the best choice for the growingplant-based protein market.InnovoPro was founded on 2013 by Dr. Ascher Shmulewitz an experienced inventor and investor, and has made considerable progress in developing chickpea proteins and other chickpea ingredients.InnovoPro has been recognized as an innovator of disruptive technology in the food industry.
- Solidify — The Marketplayz platform helps you find the perfect creators to promote your products. It utilizes AI-powered technology to enable advertisers and creators to connect through a one-stop, self-service marketplace.
- Geneyx — Geneyx offers a superior NGS data analysis and interpretation platform, Harnessing genetic data to guide digital insights for rare and germline disorders.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jacky is dedicated to angel investment and has built up a portfolio of more than thirty startup companies in Canada and the US. His target investments are the early-stage B2B companies with disruptive technologies and business potential in enterprise software, information technologies, MedTech, and Advanced Manufacturing.Jacky has acquiredconcrete business experiences as a successful founder in the startup ecosystem and an executive of Fortune 500 companies over two decades. His remarkable accomplishments range from building startups from scratch to leading a billion-dollar business with the leverage of 14,000 enterprise channel partners. The unique journey has shaped Jacky's outstanding of investing in early startups.Jacky holds the degrees of Mater's E.E. and MBA, and he graduated from CEIBS and The Wharton Business School of the University of Pennsylvania.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Canada, United States, China
Investor stats
- Total investments: 20
- Round size: Seed $500k–$3.1M; Pre-Seed $362k–$1.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Workwolf — Workwolf is a Toronto-based start-up with a management team who has led 7 start-ups, had 2 successful exits, and has taken a company public with a $1.8B IPO. Workwolf CEO Erik Simins is an SME in HR who previously founded MAGNUS HRS, a staffing company now servicing over 150 enterprise customers. The technology at Workwolf solves two of the biggestpain points in employment: applicant filtration and verification, and does so by empowering users to identify better candidates faster. Winner of global awards in both 2020 and 2021 for innovation and market potential, Workwolf is ramping up for its multi-national roll-out with ManpowerGroup in September that will coincide with a $4.5M Seed financing round.
- Agile Devices — Agile Devices offer catheter-based interventional procedures helping patients during a stroke. It helps medical practitioners reduce the procedure time to respond to time bound emergencies.
- Traction Technology Partners — Traction is a powerful SaaS collaboration platform for evaluating, adopting and managing new technologies across the enterprise. The platform includes Project Management and CRM tools designed specifically for enterprise teams tasked with discovering and evaluating new technologies. Traction is used by IT, Innovation and Corp Dev teams toaccelerate their digital transformation projects, and to speed up the way they find, manage, and adopt new technologies. Traction also offers On-Demand Research services delivered through its platform.
Fred has served as our Chief Executive Officer since April 2016. As CEO, he has led the transformation of IMV into a leading clinical-stage immune-oncology company with world-class collaborators and a strong scientific foundation. He has more than 21 years of experience in the biopharmaceutical industry, having served in several managementpositions encompassing business development, intellectual property, strategic planning, pre-marketing, and communication. Before joining IMV, Fred spent 14 years at Medicago serving in many roles of increasing responsibility, most recently as Vice President of Business Development and Strategic Planning. He had been an integral part of Medicago’s success, including securing more than $300M CAN in non-dilutive funding in revenues and future milestones from licensing agreements and government contracts, and the $357M CAN deal acquisition by Mitsubishi Pharma in 2013.Fred is also a Director of CQDM, a biopharmaceutical research consortium and served as second Vice-Chair of the Vaccine Industry Committee of Biotech Canada between 2012 and 2016. Prior to Medicago, Fred was Licensing Manager at the University Paris VII-Denis Diderot, one of the largest sciences and medical university in France. He owns a BSc degree in Biology and a Master’s degree in Biotechnology and Business Management from the University of Angers (France).
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Canada
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Saguaro Technologies — Saguaro Technologies offers innovative cell culture products that help scientists work with in vitro models that are more predictive of results in clinical trials with humans.
Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor Professor Stuart Schreiber and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Dr. Ethan Perlstein developed an approach to studying old drugs anddiscovering new drugs in model organisms called evolutionary pharmacology. Ethan is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.
Show more...Investment focus
- Industry: Biotechnology, Cannabis, Biopharma
- Stage:Seed
- Geography: United States, Canada
Investor stats
- Total investments: 4
- Round size: Seed $2M–$4.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Epinoma — Epinoma is a diagnostics company that focuses on the multi-omics approach to cancer monitoring. It engineers proteins that control the operating system of biology. The company was founded in 2020 and is headquartered in San Francisco, California.
- BluumBio — BluumBio develops next-generation remediation technologies that clean up pollution and restore degraded ecosystems
- Promakhos Therapeutics — A Boston-based biotech startup developing therapeutics.
Jed McCaleb is based out of San Francisco, California and is the Founder of Vast. Jed previously worked at Ripple as a Co-Founder.
Show more...Investment focus
- Industry: Internet, Payments, Space Travel
- Stage:Seed, Series A, Initial Coin Offering
- Geography: United States, Canada
Investor stats
- Total investments: 7
- Round size: Seed $1M–$4.6M; Series A $40M–$300M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bold Financial Technologies — Bold Financial Technologies is a payment and compliance operations for on-demand service operators. It's payouts stack to pay new publishers globally offers a REST API integration, from background checks to driving record screening and local currency payouts; and provides Bold Payouts platform, a solution for marketplaces to leverage a singleintegration that offers a back-office payout infrastructure.Bold Financial Technologies streamlines the process of mass payouts while exponentially growing the international reach of its clients. It also provides a complete administrative platform, including Tax tracking and reporting, recipient onboarding, a client administrative portal, a recipient portal, and an API.It was founded in 2014 and is headquartered in San Francisco, California.
- Stream Token — Stream is a new decentralized blockchain-based token that allows livestreamers to easily and anonymously accept payments from their audience members anywhere in the world, with extremely low transaction fees and no platform lock-in.
- Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.
Lee Lau is a Partner and Co-Founder of Alignvest Management Corporation. Mr. Lau co-founded ATI Technologies in 1985 and built the company into one of the world’s largest supplier of graphic chips and add-in boards to the personal computer industry. In addition to managing the company, Mr. Lau was ATI’s largest shareholder, first employee andresponsible for innovation and development of all products. Mr. Lau helped build ATI into a TSX and NASDAQ listed global market leader, with annual sales in excess of $2.2 billion and over 3,000 employees. ATI was sold in 2006 to Advanced Micro Devices for cash and stock consideration of $5.3 billion. Since then, Mr. Lau has managed his family office investing in a variety of alternative asset products. Prior to founding ATI, Mr. Lau held various design engineering positions with Mitel, Motorola and Plessey.Mr. Lau holds a Masters in Engineering and a BASc from the University of Toronto.
Show more...Investment focus
- Industry: Software, Wearables, Internet of Things
- Stage:Seed, Convertible Note
- Geography: Canada
Investor stats
- Total investments: 4
- Round size: Seed $788k–$1.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nymi — Nymi provides a new paradigm for connecting people to their workplace on a platform, which streamlines work securely across different networks and environments. Passwordless, contactless, handsfree.
- Lumotune — We are creating a platform to transform the world’s glass into digital displays.
- Springdel — Move beyond cloud and legacy MDM with an enterprise-grade EdgeOps platform purpose-built for the interactive Edge of Things.
Lip-Bu Tan is based out of Santa Clara, California, and is the Chief Executive Officer of Intel. Lip-Bu previously worked at Cadence Design Systems as a President and Chief Executive Officer. Lip-Bu Tan attended Nanyang Technological University.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Semiconductor
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, India
Investor stats
- Total investments: 91
- Round size: Seed $3M–$40M; Series A $8M–$60M; Series B $13M–$70M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Lamini — Lamini is the world's most powerful LLM engine, unlocking the power of generative AI for every company by putting their data to work.
- Contextual AI — Replace DIY complexity with the context engineering platform built for accuracy. Ship production-grade AI that is secure, scalable, and specialized.
- SignalRank — SignalRank Corporation is a FinTech company in the Venture space. It focuses on the seed stage asset class and uses data analytics to allocate capital to the best seed fund managers for their top performing companies. GPRank and CompanyRank are two proprietary algorithms it leverages to automate capital allocation. The company invests from balancesheet. Its customers are seed stage investors with outstanding companies in their portfolio.
Nilesh is co-founder and CTO of Aislelabs and he leads the product development and engineering. Before Aislelabs, Nilesh co-founded Sysomos in 2007. Sysomos went on to become the most advanced social media analytics platform of its kind, serving 70% of the Fortune 50 enterprises, and was later acquired in 2010. Nilesh is also an angel investorand advisor to a number of startups and incubators including Extreme Startups, MaRS Jolt, Bionym, and Granify. Nilesh has significant experience in building robust and scalable software systems, data management platforms and big data analytics solutions. Nilesh's work has appeared in leading research forums worldwide.Nilesh holds a PhD, Computer Science from the University of Toronto, and a B.Tech. Computer Science and Engineering from the Indian Institute of Technology (IIT) Bombay.
Show more...Investment focus
- Industry: SaaS, Big Data, Hardware
- Stage:Seed
- Geography: Canada
Investor stats
- Total investments: 2
- Round size: Seed $1.4M–$1.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nymi — Nymi provides a new paradigm for connecting people to their workplace on a platform, which streamlines work securely across different networks and environments. Passwordless, contactless, handsfree.
- Granify — Granify is an e-commerce conversion and revenue optimization technology powered by machine learning that regularly brings top retailers 3%-5% uplift.
Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Series A, Angel
- Geography: United States, Canada, India
Investor stats
- Total investments: 152
- Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$13M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
- BuildForever — BuildForever build products that feel personal, magical and deeply human.
- Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Lance Tracey - Founding Partner @ Full Stack
Show more...Investment focus
- Industry: Internet, Software, Communities
- Stage:Seed, Angel, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 7
- Round size: Seed $1M–$4M; Angel $1M–$1M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Taloflow — Taloflow analyzes 4,000+ vendor data points to provide you with the best possible recommendation for cloud object storage. Complete a 5-minute use case questionnaire to get started.
- SceneBox — SceneBox helps computer vision engineers sift through their large datasets to uncover the failure states and interesting data they need to train machine learning models faster.
- Quantified Citizen — Join groundbreaking studies, receive rich health insights and make an impact on global health and science. Download Quantified Citizen today!
Prior to Maginatics, Amarjit co-founded and helped lead three companies that built lasting technologies. He was co-founder and VP of business development and sales at SiByte (acquired by Broadcom), co-founder and EVP of business development and sales at PA Semi (acquired by Apple), and co-founder and CEO of Agnilux (acquired by Google).Earlierin his career, Amarjit was director of sales for strategic accounts in Digital Equipment Corporation’s semiconductor group. After that business unit was purchased by Intel, he served in a similar capacity for Intel. Amarjit also worked for many years at Texas Instruments in its technical sales organization.Amarjit received a BS degree in Electrical Engineering from San Jose State University.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Convertible Note
- Geography: United States, Canada
Investor stats
- Total investments: 14
- Round size: Seed $1.1M–$12M; Series A $21M–$30M; Convertible Note $1.3M–$2.3M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Asato — Asato is a Business Observability solution designed to help CIOs oversee all their distributed assets.*
- Virtue AI — Virtue AI operates as an AI security and compliance platform for applications.
- Gimlet Labs — Gimlet Labs is an applied research lab focused on building high performance AI systems.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Daniel Debow is the Chair of the Board of Build Canada. He attended the Stanford Law School.Daniel is the Vice President of Product (Demand) at Shopify. He previously worked as an SVP at Salesforce.com, where he drives marketing for Salesforce Work.com, a sales performance management solution that helps Facebook, LinkedIn, Spotify, and otherinnovative companies align, motivate, and drive the performance of their sales teams. Prior to joining Salesforce, Daniel was co-founder and co-CEO of Rypple, a social performance management platform acquired by Salesforce in 2012. Prior to Rypple, Daniel was on the founding team of Workbrain, which provided workforce management solutions to Wal-Mart, Citibank, and other large enterprises. Workbrain grew to $100 million in annual revenues before being acquired by Infor in 2007.A sought after speaker on how social media is changing the workplace, Daniel is a contributor to Fortune.com and the Huffington Post. He’s been widely quoted in Wired, the Financial Times, the Economist and Bloomberg Businessweek. Daniel holds a JD/MBA from the University of Toronto and an LLM in Law, Science and Technology from Stanford University.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 14
- Round size: Seed $788k–$8.3M; Series A $13M–$32M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Shakepay — Shakepay allows Canadians to buy/sell bitcoin and pay their friends. We're on a mission to create open access to building wealth.
- Spatial — Experience virtual NFT art exhibitions, meetups, and live events together with lifelike avatars. Customize beautiful 3D spaces. Join now from Web, Mobile, & VR.
- Haloo — Navigating the trademark search and registration process can be daunting and onerous for business owners and entrepreneurs. Heirlume is the first self-serve online trademark search and registration platform that integrates sophisticated legal thinking with technology. We make the complex trademark search and registration process fast, accurate,trusted and affordable for entrepreneurs and enterprise/e-com partners. Our search tool instantly runs the country-specific legal tests (i.e., “likelihood of confusion”) and performs lawyer analysis. Intelligent search algorithms provide an at-a-glance opinion of registerability (conflicts, descriptiveness, obscenity), displayed in simple visuals. Distilling the multiple data sets involved with drafting a trademark application requires time-consuming legal analysis. Our machine learning auto-suggest trademark application builder performs the lawyer work and removes room for error. While our first go to market strategy will target SME individual users, we see huge potential in expanding our market reach through key B2B partnerships as an upsell/add-on to a domain purchase (GoDaddy), or store set-up (Shopify or Amazon). Ultimately, we believe we can make trademark registration quick, easy and affordable, similar to the experience of registering a domain.
Jon Oringer is the founder and chairman of Shutterstock.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 133
- Round size: Seed $1.1M–$5.5M; Pre-Seed $100k–$3.3M; Series A $4M–$31M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- SLUSHY — SLUSHY is a secure mobile web based platform for content creators to find, grow, & monetize their audiences. A creator first, tech-driven tool, designed with key discoverability features and audience insights. In a market where existing solutions (OnlyFans, Patreon) fall short of their creators' demands, SLUSHY provides an alternativesolution for professional content creators that prioritizes their monetization, support and management needs. SLUSHY incorporates a powerful legal framework, with robust compliance tools including simplified consent, ID verification, and content moderation. The new home of unrestricted content, SLUSHY is here.
- Unsloth AI — Unsloth is an open-source, no-code web UI for training, running and exporting open models in one unified local interface.
- OneImaging — OneImaging makes life-saving diagnostics affordable, accessible, and personal. We connect employers, health plans, and members to a trusted national network of imaging centers, delivering faster answers with transparent pricing and premium care across MRIs, CT scans, ultrasounds, mammograms, X-rays and more. We serve organizations looking to control medical spend and individuals who need reliable results without delays. Every scan booked through OneImaging is proof that healthcare can be simpler, cheaper, and kinder.
Rami Essaid is the Co-Founder and Chief Executive Officer of Finmark, a Venture Partner at IDEA Fund Partners, and an Extended Team Member of Ubiquity Ventures. He was the Co-Founder and Chairman of Distil. Rami helps enterprises embrace the cloud to improve their scalability and reliability while maintaining a high level of security.He attendedNorth Carolina State University where he majored in computer engineering.
Show more...Investment focus
- Industry: SaaS, Software, News
- Stage:Seed, Pre-Seed
- Geography: United States, India, Canada
Investor stats
- Total investments: 6
- Round size: Seed $1k–$20M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Henry — Henry is an AI copilot for commercial real estate brokers that integrates internal and external data to quickly generate deal decks.
- Prospectify — #1 trusted site to buy youtube subscribers India. Offer high quality, safe and legit buy youtube subscribers cheap prices and order starts in 24-48 Hrs
- Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.
Dan Schultz
Show more...Investment focus
- Industry: SaaS, Data Mining, Life Science
- Stage:Seed
- Geography: Canada, United States
Investor stats
- Total investments: 2
- Round size: Seed $1M–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Prospectify — #1 trusted site to buy youtube subscribers India. Offer high quality, safe and legit buy youtube subscribers cheap prices and order starts in 24-48 Hrs
- Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.
Collin Terpstra is an allergy specialist.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A
- Geography: Canada
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kenota Health — Kenota Health develops next-generation rapid point-of-care system intended to be used for allergy testing in humans. Kenota's diagnostic tools are safe, simple, and offer a cheaper alternative to allergy testing using a thorough non-invasive technology, enabling physicians to improve patient outcomes.
Ryan Pawell (Founder, Director & Chief Executive Officer) is a Y Combinator alumni, published author and subject matter expert in the areas of fluid dynamics, advanced manufacturing, and biomicrofluidics. Ryan has been invited to present his work by the Australian National Fabrication Facility, White House Cancer Moonshot Taskforce, Air Force,National Institutes of Health, and National Cancer Institute among others.
Show more...Investment focus
- Industry: Medical, Biopharma, Biotechnology
- Stage:Seed
- Geography: Canada, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pioneer Fund — 300+ YC alumni investing in the top YC startups
- Avro — Avro Life Science is developing skin patches for generic drug delivery, focusing on therapeutics for children and the elderly. The core of our technology is a novel biopolymer which is used as a platform for passive transdermal drug delivery of small molecules and drugs.
Dennis Bennie is a pioneer, entrepreneur and innovator in the Canadian technology industry. Over the past 20 years, Bennie's entrepreneurial management has powered Mission Electronics, Ingram Canada and Delrina. In 1997, he founded the XDL Venture Capital Fund, focusing on information technology opportunities. The $25 million fund hasyielded exceptional returns to date. One of its most noteworthy investments was a 1997 start-up, Delano Technology Corporation (NASD:DTEC). XDL Intervest, a $150 million fund was started in 1999 and is now fully invested. Bennie currently manages an experienced team investing in private equity opportunities as the XDL Capital Group. From 1988 to 1996, Mr. Bennie was CEO of Delrina Corporation, an independent software developer and publisher, which forged the new software categories of electronic forms and PC fax communications. Under Mr. Bennie's leadership, Delrina pioneered the development of PC fax software called WinFax and became a world leader in the communication software market with annual sales revenue exceeding $130 million. Listed on both the Toronto Stock Exchange and NASDAQ, Delrina cultivated a reputation for leadership, growth and profitability, and completed several public offerings. In November 1995, the company was successfully sold to Symantec Corporation for share consideration valued at $560 million. Mr. Bennie entered the world of technology in 1979, when he co-founded Mission Electronics. He drove the expansion of this leading British audio equipment manufacturer to become a dominant force in the high-end stereo market. In 1982 he sold his interest in Mission Electronics and founded Aviva Software, an independent, mass-market software developer. Under his direction, the company expanded its scope to include software distribution and merged with Ingram Micro Inc. in 1986 to become Canada's largest software distributor. Residing in Toronto, Canada, with his wife Laura and three daughters, Dennis is an avid golfer and runner. A member of the World President's Organization, he also regularly serves on various charitable boards including the Toronto Hospital Board.
Show more...Investment focus
- Industry: Software, Hardware, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 12
- Round size: Seed $731k–$15M; Pre-Seed $20k–$4.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Delphia — Delphia puts your data to work for you.
- Tread — Tread's construction fleet management software makes the business of moving construction materials easier and more profitable. Request a demo today!
- Thriver — Discover, book, and manage workplace culture services and employee experiences all in one place. Empower your team with effective employee engagement activities.
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 54
- Round size: Seed $150k–$6.7M; Pre-Seed $110k–$1.5M; Series A $13M–$55M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
- Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Haig Farris is one of Canada's best-known venture capitalists and experts in high-technology start-ups and turn-arounds, with a varied 30+ year history of involvement, commitment, and management. He has a law degree from the University of Pennsylvania. He is co-founder and former Executive Chair of the Board of Directors of D-Wave, and he isthe President of Fractal Capital, a private venture capital company financing high technology start-ups and resource service technology companies.Previously, Dr. Farris was a co-founder and partner of the Ventures West Management group of venture capital funds (1972-1990). In 2001, he received the British Columbia Technologies Industry Association's (BCTIA) Bill Thompson Award.He was awarded an Honorary Doctor of Laws degree from UBC in 1997 and named A Pioneer of Innovation by the Vancouver Board of Trade in 2001.
Show more...Investment focus
- Industry: Biotechnology, Genetics, Life Science
- Stage:Seed, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
- Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.
Lawrence Bloch, M.D., J.D. is the former President of Infinity. He joined the company as chief financial officer and chief business officer in 2012 and has played a key role in developing and executing the company’s corporate and financial strateBeforeior to joining Infinity in 2012, Dr. Bloch served as chief executive officer of NeurAxon, Inc., acompany focused on developing next-generation pain therapeutics, from 2007 to 2011. Previously, he served as chief business officer and chief financial officer of NitroMed, Inc., raising $150 million in equity and $20 million in venture debt to support the commercial launch of BiDil®. From 1999 to 2004, he served as chief financial officer and vice president of business development of Applied Molecular Evolution, Inc., leading the company’s $101 million initial public offering and $420 million merger with Eli Lilly and Company.Dr. Bloch began his career as an emergency medicine resident physician at Massachusetts General Hospital and Brigham & Women’s Hospital. He holds a J.D. from Harvard Law School, an M.D. from Harvard Medical, School, and an MBA from Harvard Business School.
Show more...Investment focus
- Industry: Neuroscience, Therapeutics, Biotechnology
- Stage:Series B, Debt Financing
- Geography: Canada
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- NeurAxon — NeurAxon, Inc. discovers and develops pain therapeutics targeting neuronal nitric oxide synthase. It has oral products in pipeline addressing acute migraine, neuropathic pain chronic daily headache, inflammatory pain, migraine prophylaxis, and severe pain. The company was founded in 2004 and is headquartered in Toronto, Canada.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Shaz Khan is the Chief Strategy Officer/Co-Founder at Vroozi
Show more...Investment focus
- Industry: Hardware, Biometrics, Health Care
- Stage:Debt Financing
- Geography: Canada
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OMsignal — Discover our range of Hexoskin and Astroskin Smart Garments for health and fitness tracking. Find the perfect Shirts and Kits for your needs today!
Sandra MacPherson
Show more...Investment focus
- Industry: Genetics, Biotechnology, Medical Device
- Stage:Seed
- Geography: Canada
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Robotics
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 49
- Round size: Seed $2.3M–$9.1M; Pre-Seed $325k–$2M; Series A $10M–$57M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
- MightyFly — MightyFly is enabling worldwide access to goods with fast, on-demand delivery services for businesses and consumers. We’re putting the infrastructure in place to connect remote locations together with long range, heavy cargo aircraft. Many areas in the world today suffer from an inability to obtain critical and often urgently needed goods andsupplies at an affordable cost. Our goal at MightyFly is to solve this problem through express, customized aerial drone delivery services. MightyFly drones will transport cargo to multiple locations in a single flight across hundreds of miles of remote terrain that is difficult if not impossible to cross with trucks or other ground vehicles. We are developing vertical-takeoff-and-landing (VTOL) drones that fly more than 300 miles, and carry payloads in excess of 50 pounds at a fraction of the cost of helicopters. Featuring automated cargo loading and unloading, and requiring no launch or recovery infrastructure, MightyFly drones will accommodate ad-hoc deliveries to undeveloped sites as well as servicing locations along established routes.
- Bear Flag Robotics — Safe, productive and efficient farming operations for the next generation of growers. Customize, Orchestrate, Automate,and Scale your fleet to your needs.
Martin LeBlanc currently works as the Chief Executive Officer for CellCarta. He previously worked at Caprion Biosciences Inc. as the Co-Founder, President, and CEO.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Canada
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Saguaro Technologies — Saguaro Technologies offers innovative cell culture products that help scientists work with in vitro models that are more predictive of results in clinical trials with humans.
Claudette is an award-winning Technology Leader with 17+ years of success leading digital transformation, optimizing infrastructure, designing new support approaches to improve service experience. She has led more than 600 IT professionals in the planning, engineering and support of workplace technologies across all BMO branches and office towers.Claudette began her IT career in healthcare at Wellesley Hospital. She later joined the Computing and Telecommunications Division at the Metropolitan Toronto Police Services. Before joining BMO, Claudette spent 4 years at Deloitte where she was a key member of the Technology Management Team.In 2008, Claudette founded Excelovate, a human services company designed to help people and enrich lives through the creation of new products and services. Her work has played a pivotal role in launching the first innovation centre in Aurora, Rap Riderz Innovation Centre.Married and a mother of two, Claudette's commitment to the community is evident in her passion for literacy and everything technological. Claudette has authored five books and in partnership with First Book Canada and other leading corporations, Claudette launched the Black Arts and Innovation Expo (BAIE) as a novel way to celebrate Black History Month. The BAIE promotes diversity and inspires excellence in Science, Technology, Engineering, Arts and Mathematics by showcasing the outstanding achievements of current innovators in the arts, entrepreneurship and technology.Claudette is a recipient of a 2014 Green4Good Visionary award and in 2015 she was hailed as a BBPA Exchange - Woman of Honor and among the Top 100 Black Women to watch in Canada.
Show more...Investment focus
- Industry: Apps, Hospital, Software
- Stage:Angel, Grant
- Geography: Canada
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Areto Labs — Areto Labs is a human-focused cyber security company that uses AI to protect people by detecting and counteracting online abuse.
- PragmaClin — PragmaClin Research Inc. is aiming to help patients monitor their symptoms faster with the use of our remote patient monitoring system, PRIMS (Parkinson's Remote Interactive Monitoring System).
Carol Leaman is the CEO of Axonify Inc., a Waterloo-based next generation eLearning company that combines gamification with brain science to revolutionize the way companies think about and deliver training to employees.Axonify makes learning stick with personalized, bite-sized information delivered in a fun, rewarding way that drives real learningtransfer and is saving companies millions. Carol won the Fortune Brainstorm Tech Pitch Competition in July 2012 against 4 other early stage technology companies garnering Axonify worldwide recognition as an emerging leader in the eLearning space.Prior to forming Axonify, Carol was the CEO of PostRank Inc. a social media engagement platform company that she sold to Google in June 2011. Carol is a serial entrepreneur and a Chartered Accountant who has been running and advising early stage technology companies for almost 15 years.
Show more...Investment focus
- Industry: Health Care, Hospital, Neuroscience
- Stage:Seed, Angel, Series A
- Geography: Canada
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- KeyOps — A revolutionary physician engagement platform that allows doctors to quickly share their expert opinions with healthcare stakeholders such as government institutions, hospitals, universities, and life science companies.
- Trusscore — Trusscore is changing residential and commercial construction with products that combine sustainable materials with nanotechnology. Our PVC-based wall and ceiling panels are easy-to-install and high-performance replacements for traditional drywall and fiber-reinforced plastic panels.
- PragmaClin — PragmaClin Research Inc. is aiming to help patients monitor their symptoms faster with the use of our remote patient monitoring system, PRIMS (Parkinson's Remote Interactive Monitoring System).
Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Angel
- Geography: United States, China, Canada
Investor stats
- Total investments: 153
- Round size: Seed $200k–$4.3M; Angel $375k–$10M; Series A $7M–$19M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- tbh — tbh is a developer of a mobile application designed to provide anonymous feedback to friends. The company's mobile application facilitates asking or answering questions, open text fields and invite abuse when combined with anonymity, enabling users to say things without repercussions and feel better about themselves from the positive feedbackon social networks.
- Bungalow — Bungalow is a residential real estate platform that provides renters with a more convenient, flexible, and communal living solution. It utilizes existing housing supply by signing long-term leases with homeowners, and offers multi-bedroom homes in some of the most desirable neighborhoods in cities throughout the United States.Bungalow offersprivate bedrooms with handpicked housemates in beautifully furnished homes across seven major cities. Each home comes furnished and includes wifi, utilities, housekeeping, and monthly community events for members.Andrew Collins and Justin McCarty founded Bungalow in 2016. Its headquarters is in San Francisco in California.
- Raydiant — Raydiant empowers brick-and-mortar organizations to deliver engaging, personalized, and measurable on-screen digital experiences to delight in-store customers and engage back-of-house employees.
Greg has a successful track record of bringing innovative solutions to the financial industry. In 1997 Greg co-founded 724 Solutions Inc., a wireless software infrastructure provider. He served as the company’s chief executive officer and led its IPO in 2000.In 1983 he founded Footprint Software Inc., a financial software company, which he sold toIBM in 1995. While at Footprint Software, Greg won the 1994 award for Canada’s Best Managed Private Company. In 1995 he won the award for Canada’s Top 40 Under 40 and in 2000 was named Entrepreneur of the Year.Greg holds a Bachelor of Arts in Computer Science from the University of Western Ontario and a double major, Biochemistry and Life Sciences from the University of Toronto.He sits on the boards of the Ontario Cancer Biomarker Network (OCBN); NoNo Inc., a company specializing in post stroke neuroprotection; and YYZ Pharmatech, which develops tools, targets, and biomarkers for pharmaceutical companies.
Show more...Investment focus
- Industry: Internet, Software, Delivery
- Stage:Seed, Series A
- Geography: United States, Canada
Investor stats
- Total investments: 6
- Round size: Seed $1.1M–$2.2M; Series A $4.3M–$7M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Nymi — Nymi provides a new paradigm for connecting people to their workplace on a platform, which streamlines work securely across different networks and environments. Passwordless, contactless, handsfree.
- PasswordBox — Say goodbye to the hassle of passwords
- Vantage — Vantage Analytics offers today’s leading online business managers a collection of powerful predictive analytics and data mining modules, served up in an accessible interface that makes data excitingly easy to work with.To make it easy to import and export your data, they have integrated connections into the most common online business services:shopping carts, web analytics and more. Just as importantly, they allow you to take immediate action through leading marketing automation tools and business apps.Vantage will inspire, guide, and support powerful marketing strategies. Leverage new customer insight to easily send targeted campaigns over email, Facebook, Twitter, Instagram, and Pinterest.Monitor campaign progress and optimize in real-time.They offer their platform on a software-as-a-service basis: Use and pay for only what you need, the rest will be ready when you are.
Jeffrey Mallett was most recently the Chairman of SNOCAP, and has a rich history and proven experience in growing technology companies. As president and chief operating officer for Yahoo Inc. from 1995-2002, Mallett helped drive extraordinary growth and success for the company while simultaneously serving as an elected member of the Board ofDirectors. Mallett joined Yahoo in 1995, when the private company consisted of 12 employees and had no revenue. He helped the company go public in 1996, and during his seven year tenure, Mallett helped build Yahoo into one of the most recognizable entertainment and media brands in the world. By 2002, Mallett managed a global workforce of 4,000 employees in 27 countries, with $1 billion in revenue, and had overseen more than 20 acquisitions for the company. Mallett is currently an owner and executive committee member of the San Francisco Giants. Prior to his tenure at Yahoo, Mallett was vice president and general manager of the consumer products division of Novell, Inc. and a member of Novell's global marketing board, where he was involved with the merger of Novell and WordPerfect Corp. in 1994. He was a founding executive team member and vice president of Reference Software, an independent worldwide leader in consumer software language services, and led the company to a successful acquisition by WordPerfect in 1992. He also served as director of the Canadian-based telecommunications company Island Pacific Telephone, where Jeff drove the start-up's growth and development until it was acquired by telecommunications giant Cable and Wireless in 1987. Mallett lives in the San Francisco Bay Area with his wife of 19 years and their two children.
Show more...Investment focus
- Industry: E-Commerce, Media and Entertainment, iOS
- Stage:Angel, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 5
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Gametime — Gametime sells last-minute tickets to the most popular events in sports, music, and theater. It makes finding the perfect live experience remarkably fast and easy. They curate an epic list of the most amazing possibilities in the city has to offer. Once the client selects their event it will examine over 10,000 potential seats and present them withthe 50 best values to select.Each curated seat option includes a panoramic high-resolution photo so their client can experience the actual view from their section. Navigate to the seat map to see price versus the location comparisons with true-to-life, full-color venue maps. Gametime delivers the tickets directly to the client's phone. Now they are offering sports, concerts, and theater events across the United States and Canada.
- Ananda Devices — High throughput microfluidic devices to accelerate drug development in neuroscience.
- Caravan Digital Studios — At Caravan, entrepreneurship runs deep. We are pioneers in the celebrity-founded model of company creation. We pride ourselves on diving into product categories that are often overlooked or untouched and creatively solving real consumer problems. Our team excels at leveraging proprietary data and reach to identify unique opportunities and build authentic brands with an immediate audience. Our extensive experience co-founding, operating and investing in companies allows us to serve as trusted partners to the artists we co-create with.
Robert Simon is the Sr. Managing Partner, IT Venture Fund at BDC.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Series A, Seed
- Geography: Canada, United States
Investor stats
- Total investments: 22
- Round size: Seed $1.2M–$2M; Series A $6.1M–$62M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Foko Retail — A cloud-based workforce management software with capabilities to manage time, attendance, scheduling, absence and employee communications globally.
- Zymeworks — Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer.
- Finch Legal — Finch Legal is a software development company that supports personal injury law firms. The company aims to provide practical and effective legal solutions, as suggested by its commitment to serving clients better and more efficiently.
Biotechnology Angel investor funding in Canada at a glance
Stats across 37 deals from 40 investors.
Access all 40 angel investors in Canada Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Angel Investors in Canada investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 40 angel investors investing in Canada Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!